SciPio Bioscience

Scipio bioscience develops a new generation of sample preparation solution for single-cell studies, in the form of user-friendly and cost-effective benchtop kits, for use in sequencing applications in clinical and basic research, with an initial focus on transcriptomics. Scipio Bioscience has developed the protocol from the initial proof-of-concept studies to a prototype kit ready for beta-testing in collaboration with several research teams. The company, founded in 2017, is hosted in the iPEPS-ICM incubator of the Brain & Spine Institute (ICM, Pitié-Salpêtrière Hospital, Paris).

Team Members
more about
Cheryl Zimberlin
Investment Director
more about
Anique ter Braake
Latest News Entry
Scipio bioscience launches commercialization in Europe of Asteria, its RNA sequencing kit

Scipio bioscience announces the launch in Europe of Asteria©, its innovative kit for sequencing RNA on individual cells on lab benchtops

Scipio bioscience raises €6.0 M Series A financing

To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing

all portfolio news